Gene ID | Gene Name | Gene Symbol | Disease Ontology ▲ |
---|---|---|---|
100696743 | RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
|
|
100709420 | glucoside xylosyltransferase 1 |
|
|
100707269 | UDP-glucose glycoprotein glucosyltransferase 1 |
|
|
100706012 | heparan sulfate 6-O-sulfotransferase 2 |
|
|
100708358 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
|
|
100698761 | protein-O-mannosyltransferase 2 |
|
|
100701749 | ALG2 alpha-1,3/1,6-mannosyltransferase |
|
|
100700826 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
|
|
100712117 | procollagen galactosyltransferase 1 |
|
|
100695119 | hyaluronan synthase 2 |
|
|
102075538 | beta-1,3-galactosyltransferase 2 |
|
|
100695026 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 |
|
|
100696236 | mannose-P-dolichol utilization defect 1b |
|
|
100700717 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-B |
|
|
100697741 | ST3 beta-galactoside alpha-2,3-sialyltransferase 3b |
|
|
100705607 | carbohydrate sulfotransferase 1 |
|
|
100710618 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 |
|
|
100698681 | GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase |
|
|
100696362 | ribitol xylosyltransferase 1 |
|
|
100694560 | ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
|
102076897 | beta-1,4 N-acetylgalactosaminyltransferase 2-like |
|
|
100691706 | UDP-glucose ceramide glucosyltransferase |
|
|
100697871 | O-linked N-acetylglucosamine (GlcNAc) transferase, tandem duplicate 1 |
|
|
100694776 | UDP-glucuronosyltransferase 2C1 |
|
|
100706120 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024